Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 18.41 | 56.46 | -67 |
| OPM % | -9.23 | 11.58 | - |
| PBDT | -2.51 | 4.55 | PL |
| PBT | -4.14 | 2.36 | PL |
| NP | -3.07 | 1.75 | PL |